MEDIPOST Co., Ltd. (KOSDAQ:078160)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,420
+90 (0.87%)
Aug 8, 2025, 3:30 PM KST

MEDIPOST Company Description

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally.

The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food.

It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis.

In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia.

Further, the company develops SMUP-IA-01 to treat osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy.

Additionally, it offers nutritional and dietary supplements under the MOVITA brand name; and CDMO services.

The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.

MEDIPOST Co., Ltd.
CountrySouth Korea
Founded2000
IndustryBiotechnology
SectorHealthcare
Employees328
CEOWon-il Oh

Contact Details

Address:
21, Daewangpangyo-ro
Seongnam-si
South Korea
Phone82 2 3465 6677
Websitemedi-post.co.kr

Stock Details

Ticker Symbol078160
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7078160009
SIC Code2836